- Home
- RCKT vs NNOX Comparison
RCKT vs NNOX Comparison
Compare RCKT & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- NNOX
- Stock Information
- Founded
- RCKT 1999
- NNOX 2011
- Country
- RCKT United States
- NNOX Israel
- Employees
- RCKT N/A
- NNOX N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- RCKT Health Care
- NNOX Health Care
- Exchange
- RCKT Nasdaq
- NNOX Nasdaq
- Market Cap
- RCKT 328.6M
- NNOX 305.7M
- IPO Year
- RCKT N/A
- NNOX 2020
- Fundamental
- Price
- RCKT $3.05
- NNOX $4.42
- Analyst Decision
- RCKT Buy
- NNOX Strong Buy
- Analyst Count
- RCKT 13
- NNOX 2
- Target Price
- RCKT $12.88
- NNOX $8.50
- AVG Volume (30 Days)
- RCKT 2.6M
- NNOX 1.3M
- Earning Date
- RCKT 08-07-2025
- NNOX 08-12-2025
- Dividend Yield
- RCKT N/A
- NNOX N/A
- EPS Growth
- RCKT N/A
- NNOX N/A
- EPS
- RCKT N/A
- NNOX N/A
- Revenue
- RCKT N/A
- NNOX $11,886,000.00
- Revenue This Year
- RCKT N/A
- NNOX $23.81
- Revenue Next Year
- RCKT $591.46
- NNOX $149.38
- P/E Ratio
- RCKT N/A
- NNOX N/A
- Revenue Growth
- RCKT N/A
- NNOX 17.36
- 52 Week Low
- RCKT $2.19
- NNOX $3.75
- 52 Week High
- RCKT $22.01
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- RCKT 49.19
- NNOX 35.94
- Support Level
- RCKT $2.83
- NNOX $4.26
- Resistance Level
- RCKT $3.22
- NNOX $4.88
- Average True Range (ATR)
- RCKT 0.17
- NNOX 0.23
- MACD
- RCKT 0.01
- NNOX -0.03
- Stochastic Oscillator
- RCKT 41.51
- NNOX 18.44
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.